One of the first-line treatments for patients with heart disease are cholesterol-lowering medications known as statins, which have been shown for years to reduce mortality
Researchers from the University of Leicester have identified a new protein involved in airway inflammation in patients with severe asthma. The results from their study
Results from a phase I trial conducted by Alnylam Pharmaceuticals suggest that a new drug class may be available to help manage patients’ cholesterol levels.
In January 2017, a US Federal Court ordered a ban on the sale of Praluent, a PCSK9 inhibitor (used for lowering cholesterol) developed by pharmaceutical
